Mitochondrial disorders

Journal of Child Neurology

Volumn 17, Issue SUPPL. 3, 2002, Pages

  DiMauro, Salvatore ^a   Andreu, Antoni L ^b   De Vivo, Darryl C ^a  

^a Columbia Univ Coll Phys/Surgeons ^*  (United States)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ADENOSINE TRIPHOSPHATASE; CELL NUCLEUS DNA; CLONAZEPAM; CORTICOTROPIN; LAMOTRIGINE; MITOCHONDRIAL DNA; MITOCHONDRIAL ENZYME; PHENYTOIN;

AEROBIC METABOLISM; AUTOSOMAL RECESSIVE INHERITANCE; BRAIN DISEASE; BRAIN METABOLISM; CHILD; COMPARATIVE STUDY; COMPLEX FORMATION; DIET THERAPY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME SUBUNIT; EPILEPSY; EXTRACHROMOSOMAL INHERITANCE; GENE MUTATION; GENETIC CODE; HUMAN; INFANCY; INFANT; KETOGENIC DIET; LEIGH DISEASE; ONSET AGE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; RESPIRATORY CHAIN; REVIEW;

CELL NUCLEUS; DNA, MITOCHONDRIAL; EPILEPSY; HUMANS; INFANT; LEIGH DISEASE; MUTATION;

EID: 17144453677     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. Wallace DC, Singh G, Lott MT, et al: Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988;242:1427-1430.
2. Holt IJ, Harding AE, Morgan-Hughes JA: Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988;1331:717-719.
3. Servidei S: Mitochondrial encephalomyopathies: Gene mutation. Neuromusc Disord 2001;11:121-130.
4. Canafoglia L, Franceschetti S, Antozzi C, et al: Epileptic phenotypes associated with mitochondrial disorders. Neurology 2001;56: 1340-1346.
5. DiMauro S: MELAS, in: GeneReviews at GeneTests-GeneClinics: Medical genetics information resource [database online]. Available at http://www.geneclinics.org. Accessed Dec 10, 2001.
6. Sue CM, Bruno C, Andreu AL, et al: Infantile encephalopathy associated with the MELAS A3243G mutation. J Pediatr 1999;134: 696-700.
7. Hirano M, DiMauro S: Clinical features of mitochondrial myopathies and encephalomyopathies, in Lane RJM (ed). Handbook of Muscle Disease. New York, Marcel Dekker, 1996, 479-504.
8. Shtilbahns A, Shanske S, Goodman S, et al: G8363A mutation in the mitochondrial DNA transfer ribonucleic acid Lys gene: Another cause of Leigh syndrome. J Child Neurol 2000;15:759-761.
9. Hirano M, DiMauro S: Primary mitochondrial diseases, in Engel J Jr, Pedley TA (eds): Primary Mitochandrial Diseases, 3rd ed. Philadelphia, Lippincott-Raven, 1998, 2563-2570.
10. Sparaco M, Bonilla E, DiMauro S, Powers JM: Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J Neuropathol Exp Neurolol 1993;52:1-10.
11. Bonilla E, Tanji K, DiMauro S, Schon EA: Neurologic and Neuropathologic Features of Mitochondrial Encephalomyopathies. New York, John Wiley & Sons, 1997.
12. DiMauro S, Kulikova R, Tauji K, et al: Mitochondrial genes for generalized epilepsies, in Delgado-Escueta AV, Wilson WA, Olson RW, Porter RJ (eds): Mitochondrial Genes for Generalized Epilepsies, 3rd ed. Philadelphia, Lippincott Williams & Wilkins, 1999, 411-419.
13. Schuelke M, Bakker M, Stoltenburg G, et al: Epilepsia partialis continua associated with a homoplasmic mitochondrial tRNASer(UCN) mutation. Ann Neurol 1998;144:700-704.
14. DiMauro S: Mitochondrial DNA: A genetic Pandora's box. Funct Neurol 2001;16:103-116.
15. Holt IJ, Harding AE, Petty RK, et al: A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990;146:428-433.
16. Tatuch Y, Christodoulou J, Feigenbaum A, et al: Heteroplasmic mtDNA mutation (T>G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet 1992;50: 852-858.
17. Santorelli FM, Shanske S, Macaya A, et al: The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh syndrome. Ann Neurol 1993;134:827-834.
18. Rahman S, Blok RB, Dahl HHM, et al: Leigh syndrome: Clinical features and biochemical and DNA abnormalities. Ann Neurol 1996;39:343-351.
19. Uziel G, Moroni I, Lamantea E, et al: The mitochondrial disease associated with the T8993G mutation of mitochondrial ATPase 6 gene: A clinical, biochemical, and molecular study in six families. J Neurol Neurosurg Psychiatry 1997;63:16-22.
20. De Vries DD, van EB, Gabreels F, et al: A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome. Ann Neurol 1993;34:410-412.
21. Santorelli FM, Shanske S, Jain KD, et al: A T>C mutation at nt 8993 of mitochondrial DNA in a child with Leigh syndrome. Neurology 1994;44:972-974.
22. Santorelli FM, Mak S-C, Vazquez-Memije ME, et al: Clinical heterogeneity associated with the mitochondrial DNA T8993C point mutation. Pediatr Res 1996;39:914-917.
23. Thyagarajan D, Shanske S, Vazquez-Memije M, et al: A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis. Ann Neurol 1995;38:468-472.
24. Campos Y, Martin MA, Rubio JC, et al: Leigh syndrome associated with the T9176C mutation in the ATPase 6 gene of mitochondrial DNA. Neurology 1997;49:595-597.
25. Makino M, Horai S, Goto Y, Nonaka I: Confirmation that a T-to-C mutation at 9176 in mitochondrial DNA is an additional candidate mutation for Leigh's syndrome. Neuromusc Disord 1998;8:149-151.
26. Dionisi-Vici C, Seneca S, Zeviani M, et al: Fulminant Leigh syndrome and sudden unexpected death in a family with the T9176C mutation of the mitochondrial ATPase 6 gene. J Inherit Metab Dis 1998;21:2-8.
27. Carrozzo R, Tessa A, Vazquez-Memije ME, et al: The T9176G mtDNA mutation affects ATP production and results in Leigh syndrome. Neurology 2001;156:687-690.
28. Tatuch Y, Robinson BH: The mitochondrial DNA mutation at 8993 associated with NARP slows the rate of ATP synthesis in isolated lymphoblast mitochondria. Biochem Biophys Res Commun 1993;192:124-128.
29. Vazquez-Memije ME, Shanske S, Santorelli FM, et al: Comparative biochemical studies in fibroblasts from patients with different forms of Leigh syndrome. J Inherit Metab Dis 1996;19:43-50.
30. Majander A, Lamminen T, Juvonen V, et al: Mutations in subunit 6 of the F1F0-ATP synthase cause two entirely different diseases. FEBS Lett 1997;412:351-354.
31. Vazquez-Memije ME, Shanske S, Santorelli FM, et al: Comparative biochemical studies of ATPases in cells from patients with the T8993G or T8993C mitochondrial DNA mutations. J Inherit Metab Dis 1998;21:829-836.
32. Noji H, Yasuda R, Yoshida M, Kinosita K Jr: Direct observation of the rotation of F1-ATPase. Nature 1997;386:299-302.
33. Block SM: Real engines of creation. Nature 1997;386:217-219.
34. Schon EA, Santra S, Pallotti F, Girvin ME: Pathogenesis of primary defects in mitochondrial ATP synthesis. Cell Dev Biol 2001;12:441-448.
35. Houstek J, Klement P, Hermanska J, et al: Altered properties of mitochondrial ATP-synthase in patients with a T>G mutation in the ATPase 6 (subunit a) gene at, position 8993 of mtDNA. Biochim Biophys Acta 1995;11271:349-357.
36. Nijtmans LG, Henderson NS, Attardi G, Holt IJ: Impaired ATP synthase assembly associated with a mutation in the human ATP synthase subunit 6 gene. J Biol Chem 2001;276:6755-6762.
37. Garcia JJ, Ogilvie I, Robinson BH, Capaldi RA: Structure, function, and assembly of the ATP synthase in cells from patients with the T8993G mitochondrial DNA mutation. J Biol Chem 2000;275: 11075-11081.
38. De Meirleir L, Seneca S, Lissens W, et al: Bilateral striatal necrosis with a novel point, mutation in the mitochondrial ATPase 6 gene. Pediatr Neurol 1995;13:242-246.
39. Santorelli FM, Tanji K, Kulikova R, et al: Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS. Biochem Biophys Res Commun 1997;238:326-328.
40. Taylor RW, Singh-Kler R, Hayes CM, et al: Progressive mitochondrial disease resulting from a novel missense mutation in the mitochondrial DNA ND3 gene. Ann Neurol 2001;50:104-107.
41. De Coo IFM, Renier WO, Ruitenbeek W, et al: A 4-base pair deletion in the mitochondrial cytochrome b gene associated with Parkinsonism/MELAS overlap syndrome. Ann Neurol 1999;45: 130-133.
42. Wibrand F, Ravn K, Schwartz M, et al: Multisystem disorder associated with a missense mutation in the cytochrome b gene. Ann Neurol 2001;50:540-543.
43. Bruno C, Martinuzzi A, Tang Y, et al: A stop-codon mutation in the human mtDNA cytochrome c oxidase I gene disrupts the functional structure of complex IV. Am J Hum Genet 1999;65:611-620.
44. Manfredi G, Schon EA, Moraes CT, et al: A new mutation associated with MELAS is located in a mitochondrial DNA polypeptide-coding gene. Neuromusc Disord 1995;5:391-398.
45. Bourgeron T, Rustin F, Chretien D, et al: Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 1995;11:144-149.
46. DiMauro S: Mitochondrial encephalomyopathies: Back to mendelian genetics. Ann Neurol 1999;45:693-694.
47. van den Heuvel L, Ruitenbeek W, Smeets R, et al: Demonstration of a new pathogenic mutation in human complex I deficiency: A 5-bp duplication in the nuclear gene encoding the 18-kD (AQDQ) subunit. Am J Hum Genet 1998;162:262-268.
48. Loeffen J, Smeitink J, Triepels R, et al: The first nuclear-encoded complex I mutation in a patient with Leigh syndrome. Am J Hum Genet 1998;63:1598-1608.
49. DiMauro S, Hirano M, Bonilla E, et al: Cytochrome oxidase deficiency: Progress and problems, in Schapira AHV, DiMauro S (eds): Cytochrome Oxidase Deficiency: Progress and Problems. Oxford, Butterworth-Heinemann, 1994, pp 91-115.
50. Adams PL, Lightowlers RN, Turnbull DN: Molecular analysis of cytochrome c oxidase deficiency in Leigh's syndrome. Ann Neurol 1997;41:268-270.
51. Zhu Z, Yao J, Johns T, et al: SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet 1998;20:337-343.
52. Tiranti V, Hoertnagel K, Carrozzo R, et al: Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet 1998;63:1609-1621.
53. de Lonlay P, Valnot I, Barrientos A, et al: A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. Nat Genet 2001;29:57-60.
54. Moreadith RW, Batsshaw ML, Ohnishi T, et al: Deficiency of the iron-sulfur clusters of mitochondrial reduced nicotinamide-adenine-dinucleotide-ubiquinone oxidoreductase (complex I) in an infant with congenital lactic acidosis. J Clin Invest 1984;74: 685-697.
55. Hoppel CL, Kerr DS, Dahms B, Roessman U: Deficiency of the reduced nicotinamide adenine dinucleotide dehydrogenase component of complex I of mitochondrial electron transport. J Clin Invest 1987;80:71-77.
56. Robinson BH, Ward J, Goodyer P, Baudet A: Respiratory chain defects in the mitochondria of cultured skin fibroblasts from three patients with lacticacidemia. J Clin Invest 1986:177:1422-1427.
57. Pitkanen S, Feigenbaum A, Laframboise R, Robinson BH: NADH-coenzyme Q reductase (complex I) deficiency: Heterogeneity in phenotype and biochemical findings. J Inherit Metab Dis 1996;19: 675-686.
58. Morris AAM, Leonard JV, Brown GK, et al: Deficiency of respiratory chain complex I is a common cause of Leigh disease. Ann Neurol 1996;40:25-30.
59. Schuelke M, Smeitink J, Mariman E, et al: Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy. Nat Genet 1999;21:260-261.
60. Kunz WS, Kudin AP, Vielhaber S, et al: Mitochondrial complex I deficiency in the epileptic focus of patients with temporal lobe epilepsy. Ann Neurol 2000;48:766-773.
61. Bourgeois M, Goutieres F, Chretien D, et al: Deficiency in complex II of the respiratory chain presenting as a leukodystrophy in two sisters with Leigh syndrome. Brain Dev 1992;14:404-408.
62. Ogasahara S, Engel AG, Frens D, Mack D: Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci U S A 1989;86:2379-2382.
63. Sobreira C, Hirano M, Shanske S, et al: Mitochondrial encephalomyopathy with coenzyme Q10 deficiency. Neurology 1997;48: 1238-1243.
64. Di Giovanni S, Mirabella M, Spinazzola A, et al: Coenzyme Q(10) reverses pathological phenotype and reduces apoptosis in familial CoQ(10) deficiency. Neurology 2001;57:515-518.
65. Musumeci O, Naini A, Slonim AE, et al: Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology 2001;56:849-855.
66. Rotig A, Appelkvist E-L, Geromel V, et al: Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet 2000;356:391-395.
67. Mourmans J, Wendel U, Bentlage HA, et al: Clinical heterogeneity in respiratory chain complex III deficiency in childhood. J Neurol Sci 1997;1149:111-117.
68. Sue CM, Karadimas C, Checcarelli N, et al: Differential features of patients with mutations in two COX assembly genes, SURF-1 and SCO2. Ann Neurol 2000;47:589-595.
69. Pequignot MO, Dey R, Zeviani M, et al: Mutations in the SURF1 gene associated with Leigh syndrome and cytochrome c oxidase deficiency. Hum Mutat 2001;17:374-381.
70. Papadopoulou LC, Sue CM, Davidson MM, et al: Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet 1999;23:333-337.
71. Jaksch M, Horvath R, Horn N, et al: Homozygosity (E140K) in SCO2 causes delayed infantile onset of cardiomyopathy and neuropathy. Neurology 2001;157:1440-1446.
72. Valnot I, Osmond S, Gigarel N, et al: Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. Am J Hum Genet 2000; 67:1104-1109.
73. Valnot I, von Kleist-Retzow J-C, Barrientos A, et al: A mutation in the human heme-A:farnesyltransferase gene (COX 10) causes cytochrome c oxidase deficiency. Hum Mol Genet 2000;9: 1245-1249.
74. Hirano M, DiMauro S: ANT1, Twinkle, POLG, and TP: New genes open our eyes to ophthalmoplegia. Neurology 2001;57:2163-2165.
75. Hirano M, Vu TH: Defects of intergenomic communication: Where do we stand? Brain Pathol 2000;10:451-461.
76. Vu TH, Sciacco M, Tanji K, et al: Clinical manifestations of mitochondrial DNA depletion. Neurology 1998;50:1783-1790.
77. Saada A, Shaag A, Mandel H, et al: Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 2001;29:342-344.
78. Mandel H, Szargel R, Labay V, et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 2001;29:337-341.
79. Dichter MA, Buchhalter JR: The genetic epilepsies, in Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL (eds): The Genetic Epilepsies. Boston, Butterworth-Heinemann, 1997, 757-783.
80. Cock H, Schapira AHV: Mitochondrial DNA mutations and mitochondrial dysfunction in epilepsy. Epilepsia 1999;40(Suppl 3):33-40.
81. Richter C, Park J-W, Ames BN: Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci U S A 1988;85:6465-6467.
82. Shigenaga MK, Hagen TM, Ames BN: Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci U S A 1994;91: 10771-10778.
83. Weindruch R, Sohal RS: Caloric intake and aging. N Engl J Med 1997;337:986-994.
84. Biervert C, Schroeder BC, Kubisch C, et al: A potassium channel mutation in neonatal human epilepsy. Science 1998;279:403-406.
85. Singh NA, Charlier C, Stauffer D, et al: A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 1998;18:25-29.
86. Steinlein OK, Magnusson A, Stoodt J, et al: An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum Mol Genet 1997;6:943-947.
87. Beal F: Aging, energy, and oxidative. stress in neurodegenerative diseases. Ann Neurol 1995;38:357-366.
88. Westerlain CG, Fujikawa DG, Penix L, Sankar R: Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia 1993;34(Suppl 1):S37-S53.
89. Cendes F, Andermann F, Carpenter S, et al: Temporal lobe epilepsy caused by domoic acid intoxication: Evidence for glutamate receptor-mediated excitotoxicity in humans. Ann Neurol 1995; 37:123-126.
90. Uusimaa J, Remes AM, Rantala H, et al: Childhood encephalopathies and myopathies: A prospective study in a defined population to assess the frequency of mitochondrial disorders. Pediatrics 2000;105(3 Pt 1):598-603.
91. Chinnery PF, Johnson MA, Wardell TM, et al: The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol 2000; 48:188-193.
92. Darin N, Oldfors A, Moslemi AR, Holme E, Tulinius M: The incidence of mitochondrial encephalomyopathies in childhood: Clinical features and morphological, biochemical, and DNA abnormalities. Ann Neurol 2001;49:377-383.
93. Sciacco M, Fagiolari D, Lamporti C, et al: Lack of apoptosis in mitochondrial encephalomyopathies. Neurology 2001;56:1070-1074.
94. Mirabella M, Di Giovanni S, Silvestri G, Tonali P, Servidei S: Apoptosis in mitochondrial encephalomyopathies with mitochondrial DNA mutations: A potential pathogenic mechanism. Brain 2000; 123(Pt 1):93-104.